Technology adds value to Biotecnol for supporting the development of Biotecnol own product candidates. Biotecnol has various types of proprietary antibody formats in development against various cancer targets.

Biotecnol is committed in building value by developing a diverse pipeline of antibody products to address unmet healthcare needs. Biotecnol applies its antibody technologies, product development and manufacturing experience to generate, support and potentially license out human antibody products.